Stay updated with breaking news from Sponsored Level. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Palovarotene is the first medicine to be submitted for regulatory approval for fibrodysplasia ossificans progressiva , an ultra-rare disease with an estimated prevalence of 1.36 per million... | May 26, 2023
Multi-year collaboration will sustain Ipsen’s presence in oncology by leveraging Marengo’s novel discovery of TCR Vβ-targeted precision T cell activation...
INFORMATION RELATING TO THE HOLDING OF THE COMBINED SHAREHOLDERS’ MEETING OF 31 MAY 2023 FORMALITIES FOR MAKING AVAILABLE AND CONSULTINGPREPARATORY...
Ipsen delivers robust sales growth in the first quarter of 2023 and confirms its full-year guidance Paris , 27 April 2023Ipsen , a global specialty-driven biopharmaceutical company,... | April 27, 2023
PRESS RELEASE Regulated Information Ipsen publishes its 2022 Universal Registration Document Paris (France), 6 April...